Rep. Kevin Hern sold Exact Sciences (EXAS)
Rep. Kevin Hern (R-OK-1) · $50K–$100K · traded Dec 19, 2022
- Transaction
- Sold
- Amount
- $50K–$100K
- Owner
- Joint
- Traded
- Dec 19, 2022
- Disclosed
- Jan 13, 2023
- Days to disclose
- 25
- Asset type
- Stock
- As filed
- Exact Sciences Corporation
- Industry
- Medical - Diagnostics & Research · Healthcare
Other trades in this filing
All of Hern's trades →- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 30, 2022 · disclosed Jan 13, 2023 · Joint
Got $7K from the company’s PAC - Jan 13, 2023$15K–$50K
$15K–$50K · Traded Dec 30, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 30, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Bought The Williams Companies WMB
$1K–$15K · Traded Dec 26, 2022 · disclosed Jan 13, 2023 · Joint
Got $21K from the company’s PAC - Jan 13, 2023$15K–$50K
Sold Wynn Resorts, Limited WYNN
$15K–$50K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$50K–$100K
$50K–$100K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$50K–$100K
Sold Hilton Worldwide Holdings HLT
$50K–$100K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$15K–$50K
$15K–$50K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
Got $5K from the company’s PAC - Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$50K–$100K
- Jan 13, 2023$50K–$100K
$50K–$100K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$250K–$500K
$250K–$500K · Traded Dec 19, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 15, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$15K–$50K
Bought Pioneer Natural Resources Company PXD
$15K–$50K · Traded Dec 15, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Bought Pioneer Natural Resources Company PXD
$1K–$15K · Traded Dec 15, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 15, 2022 · disclosed Jan 13, 2023 · Joint
Got $6K from the company’s PAC - Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 15, 2022 · disclosed Jan 13, 2023 · Joint
Got $20K from the company’s PAC - Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 13, 2022 · disclosed Jan 13, 2023 · Joint
Got $26K from the company’s PAC - Jan 13, 2023$1K–$15K
Bought Rockwell Automation ROK
$1K–$15K · Traded Dec 12, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Bought Exxonmobil Holdings XOM
$1K–$15K · Traded Dec 9, 2022 · disclosed Jan 13, 2023 · Joint
Recent Congress trades in EXAS
- Apr 3, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Mar 24, 2026 · disclosed Apr 3, 2026 · Dependent
- Jun 8, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded May 10, 2024 · disclosed Jun 8, 2024 · Joint
- Mar 7, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Exact Sciences EXAS
$1K–$15K · Traded Feb 1, 2024 · disclosed Mar 7, 2024 · Joint
- Feb 11, 2024$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Jan 2, 2024 · disclosed Feb 11, 2024 · Dependent
- Dec 8, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Exact Sciences EXAS
$1K–$15K · Traded Nov 13, 2023 · disclosed Dec 8, 2023 · Joint
- Nov 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Oct 16, 2023 · disclosed Nov 11, 2023 · Joint
- Oct 15, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Exact Sciences EXAS
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Jun 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Exact Sciences EXAS
$1K–$15K · Traded May 1, 2023 · disclosed Jun 11, 2023 · Joint
Company context for EXAS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
EXAS: third_quarter 2026 lobbying report
H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests
Public: Oct 16, 2026, 11:03 PM EDTOriginal source ↗EXAS: second_quarter 2026 lobbying report
H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests
Public: Jul 18, 2026, 7:41 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.